EOLSSMALL

Evolus, Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$6.59
$0.00(-1.63%)
52W$3.86
$10.20
Updated Jun 22, 02:00 AM
RSI56
RS Rating85/99
Beta1.12
Volatility69%
F-Score3/9
Mkt Cap$434M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Evolus, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 85), indicating clear outperformance against the broad market. Earnings growth of 47% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.

Relative Strength
85
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.12
vs S&P 500
ABOVE MKT
52W Position
43%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$5.98
50 SMA > 100 SMA$5.27
100 SMA > 150 SMA$5.66
150 SMA > 200 SMA$5.90

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.52+1.14%ABOVE
50 SMA$5.98+10.17%ABOVE
100 SMA$5.27+24.95%ABOVE
150 SMA$5.66+16.51%ABOVE
200 SMA$5.90+11.64%ABOVE

Price Performance

1D-1.6%
1W+1.8%
1M+0.9%
3M+37.3%
6M-7.7%
YTD-1.3%
1Y-28.7%
3Y-6.5%
52-Week Trading Range43% from low
$6.59
52W Low$3.86
52W High$10.20

Technical Indicators

RSI (14)NEUTRAL
56.1
305070
Setup ScoreCOOL
4/10
Base depth: 47.4%

Risk Profile

Beta
1.12
52W Vol
69%
ATR
$0.33
Max DD (1Y)
-60%

Volume Analysis

Today
362.8K
50D Avg
757.5K
Vol Ratio
0.48x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-50%
$-0.27
Q3'25+20%
$-0.24
Q4'25+102%
$0.00
Q1'26+47%
$-0.16
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+39.36%
3 Years:+25.98%
TTM:+9.42%

Compounded Profit Growth

10 Years:+7.10%
5 Years:
3 Years:
TTM:+24.94%

Stock Price CAGR

10 Years:-5.36%
5 Years:-12.29%
3 Years:-6.46%
1 Year:-28.71%

Return on Equity

10Y Avg:-1343.4%
5Y Avg:-703.7%
3Y Avg:-913.1%
Last Year:

Key Metrics

Market Cap$434M
Gross Margin64.9%
Net Margin-17.4%
Piotroski F-Score3/9

Frequently Asked Questions

Is EOLS in an uptrend right now?

EOLS has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is EOLS overbought or oversold?

EOLS's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is EOLS outperforming the market?

EOLS has a Relative Strength (RS) Rating of 85 out of 99. Yes, EOLS is a market leader, outperforming 85% of all stocks over the past 12 months.

Where is EOLS in its 52-week range?

EOLS is trading at $6.59, which is 65% of its 52-week high ($10.20) and 43% above its 52-week low ($3.86).

How volatile is EOLS?

EOLS has a Beta of 1.12 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.